RECENT NEWS

Routine monitoring at sewage treatment works could provide a powerful early warning system for the next influenza or norovirus epidemic.

Register now for the British Society for Microbial Technology (BSMT) 38th Annual Microbiology Conference, as early bird booking rates are only available until 10 April.

Lunaphore, a Swiss life-sciences company developing technology to enable spatial biology in every laboratory, has expanded its COMET platform and product suite, which now includes a wide range of tools and applications across all research and drug development stages.

A consultation is open on recommendations that NHS England should collect and process information on healthcare activity carried out at private hospitals. Plans to create a single source of healthcare data in England to improve the quality of care for patients are the focus of a consultation which is part of the Acute Data Alignment Programme (ADAPt).

Register now for the British Society for Microbial Technology (BSMT) 38th Annual Microbiology Conference, as early bird booking rates are available until 10 April.

Source Genomics is the first UK-based commercial service provider of Olink Proteomics. The company has partnered with Olink to maximise the power of proteomics, providing high-throughput and scalable biomarker discovery for laboratory projects with unparalleled specificity.

Fujirebio has announced the availability of the Lumipulse G NfL CSF and Lumipulse G NfL Blood assays for the fully automated random-access LUMIPULSE G immunoassay systems.

Thermo Fisher Scientific and the University of California, San Francisco (UCSF), will accelerate advanced cell therapies for difficult to treat conditions, including cancer, rare diseases, and other illnesses, from a newly opened cGMP manufacturing facility adjacent to UCSF Medical Center’s Mission Bay campus.

The government has published a new plan to promote cyber resilience across the health and care sectors by 2030, protecting both services and patients.

National pharmacy retail chain Boots has announced a UK-wide diabetes screening pilot which will offer a private screening service to customers using the LumiraDx platform and HbA1c test.

Bio-Rad Laboratories has launched the new PTC Tempo 96 and PTC Tempo Deepwell thermal cyclers, designed to optimise PCR applications such as sequencing, cloning, and genotyping.

Proxim Diagnostics, a company developing a handheld, point-of care diagnostic device, announced it has received a strategic investment from bioMérieux, a world leader in the field of in vitro diagnostics.

A series of new measures will be introduced by the Medicines and Healthcare products Regulatory Agency (MHRA) with support from partners to make it faster and easier to gain approval and to run clinical trials in the UK.

PerkinElmer has successfully completed the previously announced divestiture of its applied, food and enterprise services businesses to New Mountain Capital, a growth-oriented investment firm.

Proscia, a leading provider of digital and computational pathology solutions, has strengthened its position in the $12 billion preclinical research and development (R&D) market with enhancements to its flagship Concentriq for Research platform.

NADMED, a start-up that offers kits and laboratory services for the measurement of NADs from any biological sample, has announced a partnership with health data company and CLIA-certified laboratory TruDiagnostic to launch a novel NAD blood test in the United States.

Dr Nicole Robb, Assistant Professor at Warwick University, Oxford University lecturer, and co-founder of healthtech company Pictura Bio, has today warned that the UK’s diagnostic testing capabilities are not advanced enough to deal with an influenza spill-over event from birds to humans quickly and efficiently. Dr Robb believes that new diagnostic technologies are needed as a priority.

INTEGRA Biosciences has acquired Miroculus, a biotechnology specialist focused on developing hands-off automation solutions for next generation sequencing (NGS) protocols.

Cystic Fibrosis (CF) Syndicate in Antimicrobial Resistance (AMR) has launched a £3 million Collaborative Discovery Programme for drug discovery innovators to accelerate the development of new treatments for people with CF.

London Medical Laboratory (LML) has improved its efficiency and enhanced annual revenue growth by deploying Cirdan’s next-generation laboratory information system, ULTRA. ULTRA improves the quality of patient care by delivering more timely and accurate results to both clinicians and patients.